交易 Y-mAbs Therapeutics, Inc. - YMAB CFD
新增到我的最愛- 概括
- 曆史數據
- 活動
- 收入報表
- 資産負債表
- 現金流
- 所有權
交易條件
價差 | 0.05 | ||||||||
多頭倉位隔夜費用
多頭倉位隔夜費用
前往平台 | -0.026151% | ||||||||
空頭倉位隔夜費用
空頭倉位隔夜費用
前往平台 | 0.003929% | ||||||||
隔夜費時間 | 21:00 (UTC) | ||||||||
最小成交量 | 1 | ||||||||
貨幣 | USD | ||||||||
保證金 | 5% | ||||||||
股票交易 | United States of America | ||||||||
交易委員會 | 0% |
*Information provided by Capital.com
Y-mAbs Therapeutics Inc ESG Risk Ratings
High Medium Low Negligible
“D”分數表示相對 ESG 表現較差,公開報告重要 ESG 數據的透明度不足。
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 關閉 | 更改 | 變化 (%) | 打開 | 高 | 低 |
---|---|---|---|---|---|---|
Sep 22, 2023 | 5.20 | 0.22 | 4.42% | 4.98 | 5.22 | 4.98 |
Sep 21, 2023 | 5.07 | 0.14 | 2.84% | 4.93 | 5.16 | 4.93 |
Sep 20, 2023 | 5.17 | -0.01 | -0.19% | 5.18 | 5.34 | 5.04 |
Sep 19, 2023 | 5.21 | 0.36 | 7.42% | 4.85 | 5.35 | 4.85 |
Sep 18, 2023 | 5.05 | 0.19 | 3.91% | 4.86 | 5.08 | 4.86 |
Sep 15, 2023 | 4.97 | 0.21 | 4.41% | 4.76 | 5.05 | 4.74 |
Sep 14, 2023 | 4.96 | 0.15 | 3.12% | 4.81 | 5.04 | 4.78 |
Sep 13, 2023 | 4.93 | 0.14 | 2.92% | 4.79 | 5.14 | 4.79 |
Sep 12, 2023 | 4.98 | -0.08 | -1.58% | 5.06 | 5.13 | 4.88 |
Sep 11, 2023 | 5.14 | 0.05 | 0.98% | 5.09 | 5.23 | 4.92 |
Sep 8, 2023 | 5.05 | 0.10 | 2.02% | 4.95 | 5.21 | 4.80 |
Sep 7, 2023 | 4.97 | 0.18 | 3.76% | 4.79 | 5.00 | 4.71 |
Sep 6, 2023 | 4.83 | -0.03 | -0.62% | 4.86 | 4.95 | 4.69 |
Sep 5, 2023 | 4.90 | -0.28 | -5.41% | 5.18 | 5.28 | 4.82 |
Sep 1, 2023 | 5.27 | 0.30 | 6.04% | 4.97 | 5.31 | 4.84 |
Aug 31, 2023 | 5.03 | -0.24 | -4.55% | 5.27 | 5.37 | 5.03 |
Aug 30, 2023 | 5.37 | 0.01 | 0.19% | 5.36 | 5.55 | 5.32 |
Aug 29, 2023 | 5.50 | 0.23 | 4.36% | 5.27 | 5.60 | 5.27 |
Aug 28, 2023 | 5.43 | 0.15 | 2.84% | 5.28 | 5.56 | 5.28 |
Aug 25, 2023 | 5.54 | -0.12 | -2.12% | 5.66 | 5.71 | 5.40 |
Y-mAbs Therapeutics, Inc. Events
时间(协调世界时) (UTC) | 國家 | 事件 |
---|---|---|
Monday, November 6, 2023 | ||
时间(协调世界时) (UTC) 10:59 | 國家 US
| 事件 Q3 2023 Y-mAbs Therapeutics Inc Earnings Release Q3 2023 Y-mAbs Therapeutics Inc Earnings ReleaseForecast(預報) -上一頁 - |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
總收入 | 65.267 | 34.897 | 20.75 | 0 | 0 |
總營業費用 | 160.078 | 150.33 | 140.685 | 83.004 | 43.23 |
銷售/一般/行政費用,總計 | 60.939 | 54.571 | 44.785 | 19.512 | 8.961 |
研究與開發 | 91.572 | 93.245 | 93.697 | 63.492 | 34.269 |
營業收入 | -94.811 | -115.433 | -119.935 | -83.004 | -43.23 |
其他,淨值 | -0.797 | -3.749 | 1.174 | 2.019 | 0.053 |
稅前淨收入 | -95.568 | -55.275 | -119.337 | -81.028 | -43.274 |
稅後淨收入 | -95.568 | -55.275 | -119.337 | -81.028 | -43.274 |
未計算非常項目前的淨收益 | -95.568 | -55.275 | -119.337 | -81.028 | -43.274 |
淨收入 | -95.568 | -55.275 | -119.337 | -81.028 | -43.274 |
普通股股東可獲收益 (不含非經常性項目) | -95.568 | -55.275 | -119.337 | -81.028 | -43.274 |
普通股股東可獲收益 (含非經常性項目) | -95.568 | -55.275 | -119.337 | -81.028 | -43.274 |
攤薄淨收入 | -95.568 | -55.275 | -119.337 | -81.028 | -43.274 |
攤薄後加權平均股 | 43.7037 | 43.1818 | 40.1185 | 35.1835 | 28.7724 |
扣除特別項目的每股攤薄盈利 | -2.18673 | -1.28005 | -2.97461 | -2.30301 | -1.50401 |
Dividends per Share - Common Stock Primary Issue | |||||
每股正常攤薄盈利 | -2.18673 | -2.71607 | -2.97461 | -2.30301 | -1.50401 |
利息收入(費用),非經營淨值 | 0.04 | 1.897 | -0.576 | -0.043 | -0.097 |
收入 | 65.267 | 34.897 | 20.75 | ||
Other Operating Expenses, Total | 0.1 | 0.21 | 2.203 | ||
收入成本,共計 | 7.467 | 2.304 | |||
毛利 | 57.8 | 32.593 | |||
Gain (Loss) on Sale of Assets | 0 | 62.01 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
總收入 | 20.751 | 20.251 | 31.447 | 12.537 | 10.797 |
收入 | 20.751 | 20.251 | 31.447 | 12.537 | 10.797 |
收入成本,共計 | 4.649 | 2.083 | 2.02 | 2.475 | 1.14 |
毛利 | 16.102 | 18.168 | 29.427 | 10.062 | 9.657 |
總營業費用 | 27.974 | 27.752 | 32.6 | 38.554 | 50.742 |
銷售/一般/行政費用,總計 | 11.27 | 11.115 | 10.793 | 13.626 | 23.082 |
研究與開發 | 12.055 | 10.072 | 19.787 | 22.453 | 26.42 |
營業收入 | -7.223 | -7.501 | -1.153 | -26.017 | -39.945 |
Gain (Loss) on Sale of Assets | 0 | 0 | 0 | ||
其他,淨值 | 1.1 | 1.111 | 2.31 | -1.509 | -1.186 |
稅前淨收入 | -6.123 | -6.39 | 1.157 | -27.526 | -41.131 |
稅後淨收入 | -6.302 | -6.39 | 1.157 | -27.526 | -41.131 |
未計算非常項目前的淨收益 | -6.302 | -6.39 | 1.157 | -27.526 | -41.131 |
淨收入 | -6.302 | -6.39 | 1.157 | -27.526 | -41.131 |
普通股股東可獲收益 (不含非經常性項目) | -6.302 | -6.39 | 1.157 | -27.526 | -41.131 |
普通股股東可獲收益 (含非經常性項目) | -6.302 | -6.39 | 1.157 | -27.526 | -41.131 |
攤薄淨收入 | -6.302 | -6.39 | 1.157 | -27.526 | -41.131 |
攤薄後加權平均股 | 43.6631 | 43.6716 | 43.6683 | 43.7183 | 43.7188 |
扣除特別項目的每股攤薄盈利 | -0.14433 | -0.14632 | 0.0265 | -0.62962 | -0.94081 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常攤薄盈利 | -0.14433 | -0.04369 | 0.0265 | -0.62962 | -0.94081 |
Other Operating Expenses, Total | 0 | 0 | 0 | 0.1 | |
異常費用(收入) | 4.482 |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流動資産總額 | 130.447 | 202.261 | 122.363 | 211.955 | 151.532 |
現金和短期投資 | 105.762 | 181.564 | 114.634 | 207.136 | 147.84 |
現金等價物 | 105.762 | 181.564 | 114.634 | 207.136 | 147.84 |
其他流動資産,總計 | 5.452 | 7.473 | 7.729 | 4.819 | 3.692 |
總資産 | 141.456 | 212.783 | 132.047 | 216.366 | 151.924 |
物業/廠房/設備,總計 - 淨額 | 2.343 | 5.689 | 6.394 | 4.041 | 0.205 |
其他長期資産,總計 | 5.68 | 3.17 | 3.29 | 0.37 | 0.187 |
流動負債總額 | 28.284 | 27.875 | 19.535 | 13.586 | 9.123 |
應付賬款 | 14.175 | 13.552 | 9.372 | 8.52 | 5.872 |
預提費用 | 14.109 | 14.323 | 10.163 | 5.066 | 3.251 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
負債總額 | 32.235 | 32.677 | 26.211 | 17.463 | 11.397 |
長期債務總額 | 0 | 0 | 0 | 0 | 0 |
其他負債,總計 | 3.951 | 4.802 | 6.676 | 3.877 | 2.274 |
總權益 | 109.221 | 180.106 | 105.836 | 198.903 | 140.527 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | ||
普通股 | 0.004 | 0.004 | 0.004 | 0.004 | 0.003 |
額外實收資本 | 543.929 | 519.206 | 391.558 | 364.712 | 225.352 |
留存收益(累計赤字) | -436.043 | -340.475 | -285.2 | -165.863 | -84.835 |
其他權益,總計 | 1.331 | 1.371 | -0.526 | 0.05 | 0.007 |
總負債和股東權益 | 141.456 | 212.783 | 132.047 | 216.366 | 151.924 |
已發行普通股總數 | 43.6701 | 43.6947 | 40.6884 | 39.7284 | 34.1937 |
應收賬款總額,淨額 | 12.531 | 7.712 | |||
應收賬款 - 貿易,淨額 | 12.531 | 7.712 | |||
總庫存 | 6.702 | 5.512 | |||
無形資産,淨額 | 2.986 | 1.663 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
流動資産總額 | 124.006 | 130.447 | 133.244 | 153.92 | 177.739 |
現金和短期投資 | 92.629 | 105.762 | 114.526 | 133.665 | 156.724 |
現金等價物 | 92.629 | 105.762 | 114.526 | 133.665 | 156.724 |
應收賬款總額,淨額 | 18.702 | 12.531 | 9.251 | 7.208 | 9.324 |
應收賬款 - 貿易,淨額 | 18.702 | 12.531 | 9.251 | 7.208 | 9.324 |
總庫存 | 8.945 | 6.702 | 6.242 | 6.794 | 5.588 |
其他流動資産,總計 | 3.73 | 5.452 | 3.225 | 6.253 | 6.103 |
總資産 | 137.445 | 141.456 | 143.915 | 165.178 | 191.047 |
物業/廠房/設備,總計 - 淨額 | 1.88 | 2.343 | 3.541 | 3.935 | 4.852 |
無形資産,淨額 | 2.898 | 2.986 | 1.53 | 1.574 | 1.618 |
其他長期資産,總計 | 8.661 | 5.68 | 5.6 | 5.749 | 6.838 |
流動負債總額 | 25.92 | 28.284 | 32.015 | 29.45 | 29.042 |
應付賬款 | 8.843 | 14.175 | 13.723 | 11.291 | 14.661 |
預提費用 | 17.077 | 14.109 | 18.292 | 18.159 | 14.381 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
負債總額 | 29.616 | 32.235 | 36.017 | 33.782 | 33.575 |
長期債務總額 | 0 | 0 | 0 | 0 | 0 |
其他負債,總計 | 3.696 | 3.951 | 4.002 | 4.332 | 4.533 |
總權益 | 107.829 | 109.221 | 107.898 | 131.396 | 157.472 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 |
普通股 | 0.004 | 0.004 | 0.004 | 0.004 | 0.004 |
額外實收資本 | 549.233 | 543.929 | 540.392 | 537.962 | 524.329 |
留存收益(累計赤字) | -442.433 | -436.043 | -437.2 | -409.674 | -368.543 |
其他權益,總計 | 1.025 | 1.331 | 4.702 | 3.104 | 1.682 |
總負債和股東權益 | 137.445 | 141.456 | 143.915 | 165.178 | 191.047 |
已發行普通股總數 | 43.6778 | 43.6701 | 43.6681 | 43.72 | 43.7182 |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
淨收入/起跑線 | -95.568 | -55.275 | -119.337 | -81.028 | -43.274 |
經營活動産生的現金 | -75.921 | -102.556 | -91.231 | -73.497 | -41.229 |
經營活動産生的現金 | 0.839 | 0.782 | 0.396 | 0.166 | 0.029 |
非現金物品 | 29.179 | -40.779 | 24.266 | 4.7 | 2.063 |
營運資金的變化 | -10.371 | -7.284 | 3.444 | 2.665 | -0.047 |
投資活動産生的現金 | 0 | 61.043 | -2.785 | -1.965 | -0.234 |
資本支出 | 0 | -0.967 | -0.175 | -1.965 | -0.234 |
融資活動産生的現金 | 0.084 | 108.314 | 2.004 | 134.704 | 98.763 |
融資現金流項目 | -1.002 | ||||
股票的發行(報廢),淨額 | 0.084 | 108.314 | 2.004 | 134.704 | 99.765 |
外彙效應 | 0.035 | 0.129 | -0.49 | 0.023 | 0.056 |
現金淨變化 | -75.802 | 66.93 | -92.502 | 59.265 | 57.356 |
其他投資現金流量項目,總計 | 0 | 62.01 | -2.61 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -6.39 | -95.568 | -96.725 | -69.199 | -28.068 |
Cash From Operating Activities | -13.124 | -75.921 | -67.26 | -48.025 | -24.925 |
Cash From Operating Activities | 0.182 | 0.839 | 0.609 | 0.383 | 0.195 |
Non-Cash Items | 4.848 | 29.179 | 25.763 | 20.457 | 5.402 |
Changes in Working Capital | -11.764 | -10.371 | 3.093 | 0.334 | -2.454 |
Cash From Investing Activities | 0 | 0 | 0 | 0 | 0 |
Capital Expenditures | 0 | 0 | 0 | 0 | |
Other Investing Cash Flow Items, Total | 0 | 0 | 0 | 0 | 0 |
Cash From Financing Activities | 0 | 0.084 | 0.084 | 0.032 | 0.032 |
Issuance (Retirement) of Stock, Net | 0 | 0.084 | 0.084 | 0.032 | 0.032 |
Foreign Exchange Effects | -0.009 | 0.035 | 0.138 | 0.094 | 0.053 |
Net Change in Cash | -13.133 | -75.802 | -67.038 | -47.899 | -24.84 |
差價合約交易計算器
計算您的假設損益
交易佣金
0
- 1:1
槓桿
1:1
- 20
- 100
- 500
- 1000
- 10000
投資
交易規模(槓桿 x 投資):
打開
關閉
做空 做多
Industry: | Bio Therapeutic Drugs |
230 Park Avenue
Suite 3350
NEW YORK
NEW YORK 10169
US
收入報表
- Annual
- Quarterly
人們也觀看
還在尋找值得信賴的經紀商?
加入全球 555.000 多名交易者,選擇與 Capital.com 交易